Billerica, Massachusetts, May 16, 2017 – MilliporeSigma is inviting chemistry graduate students in their third year or beyond to enter research projects for a chance to compete for the $5,000 Alfred R. Bader Award for Student Innovation grand prize. The award has been given over the past 10 years to up-and-coming chemists in honor of Sigma-Aldrich cofounder Alfred R. Bader.
Four finalists will each receive $500 in cash or prizes and all-expense paid travel to the Bader Student Chemistry Symposium Sept. 7 at the company’s Innovation Center in Darmstadt, Germany. Following student presentations, one $5,000 grand prize will be announced. The deadline to enter is June 16.
Program focus:
· Development of new reagents, catalysts, ligands, technologies, software, labware or instrumentation broadly applicable to synthetic organic chemistry.
· Creative use of current reagents, catalysts and ligands in methodology or total synthesis projects.
Submission materials:
· Research summary highlighting the applicant’s individual contribution to the project and the impact of the work on the chemistry or scientific community (1,000 words, Microsoft Word document, 10-point Arial font).
· A 100-word personal statement about the student’s experience with innovation in chemistry.
· Completed 2017 Bader Award application at sigma-aldrich.com/baderaward.
Eligibility:
· Applicant must have completed three full years of graduate work and be in good academic standing.
· Limited to the first 200 applicants worldwide.
· Applicants must be able to attend the Bader Student Chemistry Symposium Sept. 7 in Darmstadt, Germany, and give a short presentation of their graduate research.
Find official award information, including printable flyers and full rules, at www.sigma-aldrich.com/baderaward.
Interested in hearing about the finalists or covering the Bader Student Chemistry Symposium in Darmstadt, Germany? Contact us to subscribe to further updates and receive a press invite.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany, completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in health care, life science and performance materials. The company has six businesses—Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials—and generated sales of €15 billion in 2016. More than 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.
Merck KGaA, Darmstadt, Germany, is the world’s oldest pharmaceutical and chemical company—since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark “Merck” internationally except for the U.S. and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
